EXPANDED ACCESS PROGRAM FOR AZTREONAMN LYSINE FOR INHALATION IN PATIENTS WITH CY

CY 患者吸入氨曲南赖氨酸的扩大使用计划

• 批准号: 7951768
• 负责人: JOANNE L BILLINGS
• 金额: $ 0.59万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951768
• 关键词: Breathing; Chronic; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Data; Deterioration; Disease Progression; Funding; Grant; Infection; Institution; Lysine; Patients; Research; Research Personnel; Resources; Risk; Source; Time; United States National Institutes of Health; base; cystic fibrosis patients; design; prevent; programs; pulmonary function

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Based on the data available to date, it is apparent that chronic AZLI therapy will be required in many patients who have limited treatment options in order to maintain and/or prevent progressive deterioration of pulmonary function. This study has been designed to provide expanded access to AZLI, 75 mg three times daily to patients with CF and PA airway infection who have limited treatment options and are at risk for disease progression.

这个子项目是众多研究子项目之一